Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.200
-0.110 (-2.55%)
Nov 26, 2025, 4:00 PM EST - Market closed
Evolent Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 2,054 | 2,555 | 1,964 | 1,352 | 907.96 | 924.64 | Upgrade | |
Revenue Growth (YoY) | -16.65% | 30.09% | 45.26% | 48.91% | -1.80% | 34.57% | Upgrade |
Cost of Revenue | 1,676 | 2,187 | 1,503 | 1,035 | 657.55 | 696.58 | Upgrade |
Gross Profit | 378.34 | 367.35 | 460.47 | 316.58 | 250.41 | 228.06 | Upgrade |
Selling, General & Admin | 273.61 | 246.65 | 306.27 | 269.27 | 207.78 | 198.04 | Upgrade |
Operating Expenses | 373.72 | 365.02 | 429.69 | 336.46 | 267.82 | 258.87 | Upgrade |
Operating Income | 4.63 | 2.33 | 30.78 | -19.88 | -17.41 | -30.81 | Upgrade |
Interest Expense | -45.18 | -24.72 | -54.21 | -15.57 | -25.43 | -28.33 | Upgrade |
Interest & Investment Income | 4.15 | 5.54 | 5.26 | 1.37 | 0.41 | 2.63 | Upgrade |
Earnings From Equity Investments | 0.52 | -3.44 | 1.29 | 4.57 | 13.18 | 10.04 | Upgrade |
Other Non Operating Income (Expenses) | -52.17 | 0.07 | -62.53 | -45.89 | -0.15 | -0.12 | Upgrade |
EBT Excluding Unusual Items | -88.05 | -20.22 | -79.4 | -75.41 | -29.4 | -46.58 | Upgrade |
Merger & Restructuring Charges | -4.82 | -16.4 | -51.84 | - | -11.72 | -3.39 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -215.1 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -47.13 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -8.11 | - | 45.94 | -0.7 | Upgrade |
Asset Writedown | -2.59 | -2.59 | -24.07 | - | - | - | Upgrade |
Other Unusual Items | -32.29 | -23.83 | -38.99 | 13.33 | -34.62 | -17.64 | Upgrade |
Pretax Income | -127.75 | -63.04 | -202.41 | -62.08 | -29.8 | -330.54 | Upgrade |
Income Tax Expense | 0.43 | -1.41 | -89.37 | -43.38 | 0.48 | -2.37 | Upgrade |
Earnings From Continuing Operations | -128.18 | -61.62 | -113.04 | -18.7 | -30.28 | -328.17 | Upgrade |
Earnings From Discontinued Operations | - | - | - | -0.46 | -7.32 | -6.07 | Upgrade |
Net Income to Company | -128.18 | -61.62 | -113.04 | -19.16 | -37.6 | -334.25 | Upgrade |
Net Income | -128.18 | -61.62 | -113.04 | -19.16 | -37.6 | -334.25 | Upgrade |
Preferred Dividends & Other Adjustments | 52.7 | 31.83 | 29.22 | - | - | - | Upgrade |
Net Income to Common | -180.89 | -93.45 | -142.26 | -19.16 | -37.6 | -334.25 | Upgrade |
Shares Outstanding (Basic) | 115 | 115 | 111 | 94 | 86 | 85 | Upgrade |
Shares Outstanding (Diluted) | 115 | 115 | 111 | 94 | 86 | 85 | Upgrade |
Shares Change (YoY) | 0.65% | 3.08% | 18.73% | 8.87% | 1.34% | 3.11% | Upgrade |
EPS (Basic) | -1.57 | -0.81 | -1.28 | -0.20 | -0.44 | -3.94 | Upgrade |
EPS (Diluted) | -1.57 | -0.81 | -1.28 | -0.20 | -0.44 | -3.94 | Upgrade |
Free Cash Flow | -115.99 | -14.35 | 113.84 | -59.08 | 11.25 | -48.29 | Upgrade |
Free Cash Flow Per Share | -1.01 | -0.13 | 1.02 | -0.63 | 0.13 | -0.57 | Upgrade |
Gross Margin | 18.42% | 14.38% | 23.45% | 23.42% | 27.58% | 24.66% | Upgrade |
Operating Margin | 0.22% | 0.09% | 1.57% | -1.47% | -1.92% | -3.33% | Upgrade |
Profit Margin | -8.81% | -3.66% | -7.24% | -1.42% | -4.14% | -36.15% | Upgrade |
Free Cash Flow Margin | -5.65% | -0.56% | 5.80% | -4.37% | 1.24% | -5.22% | Upgrade |
EBITDA | 79.84 | 94 | 127.5 | 20.32 | 16.13 | 5.76 | Upgrade |
EBITDA Margin | 3.89% | 3.68% | 6.49% | 1.50% | 1.78% | 0.62% | Upgrade |
D&A For EBITDA | 75.21 | 91.67 | 96.72 | 40.2 | 33.54 | 36.58 | Upgrade |
EBIT | 4.63 | 2.33 | 30.78 | -19.88 | -17.41 | -30.81 | Upgrade |
EBIT Margin | 0.22% | 0.09% | 1.57% | -1.47% | -1.92% | -3.33% | Upgrade |
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.